Search Results - "Müllinger, B"

Refine Results
  1. 1

    First-In-Man Dose Escalation Study of Aspirin® Inhaled For The Clinical Development of A New Antiviral Treatment of Resistant Influenza by Nagelschmitz, J, Scheerans, Ch, Kraetzschmar, J, von Degenfeld, G, Müllinger, B, Wensing, G

    Published in Clinical therapeutics (01-08-2015)
    “…Introduction D, L-lysine acetylsalicylate (ASA) glycine (LASAG, Aspirin i.v.®) has antiviral activity including resistant viral strains: inhalation of…”
    Get full text
    Journal Article
  2. 2

    Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial by Bakker, E.M., Volpi, S., Salonini, E., Müllinger, B., Kroneberg, P., Bakker, M., Hop, W.C.J., Assael, B.M., Tiddens, H.A.W.M.

    Published in Pediatric pulmonology (01-02-2014)
    “…Introduction Small airway obstruction is important in the pathophysiology of cystic fibrosis (CF) lung disease. Additionally, many CF patients lose lung…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Increased sputum IL-8 and IL-5 in asymptomatic nonspecific airway hyperresponsiveness by Betz, R, Kohlhäufl, M, Kassner, G, Müllinger, B, Maier, K, Brand, P, Weber, N, Häussinger, K, Heyder, J, Frankenberger, M

    Published in Lung (01-03-2001)
    “…Since asymptomatic, nonspecific airway hyperresponsiveness (BHR) may be due to an enhanced local inflammatory response, we studied molecular markers of…”
    Get full text
    Journal Article
  5. 5

    PULMONARY DEPOSITION OF MONODISPERSE AEROSOLS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE by Meyer, T., Müllinger, B., Sommerer, K., Scheuch, G., Brand, P., Beckmann, H., Häussinger, K., Weber, N., Siekmeier, R.

    Published in Experimental lung research (01-10-2003)
    “…In order to improve patient convenience and drug availability for patients with α 1 -protease inhibitor deficiency, the administration via the inhalation route…”
    Get full text
    Journal Article
  6. 6

    Laser diffraction characterization of droplet size distributions produced by vibrating mesh nebulization in air and a helium–oxygen mixture by Martin, A.R., Gleske, J., Katz, I.M., Hartmann, M., Mullinger, B., Haussermann, S., Caillibotte, G., Scheuch, G.

    Published in Journal of aerosol science (01-12-2010)
    “…Medical aerosols may be delivered in combination with gases other than air, thus it is of interest to assess the effects of gas properties on the…”
    Get full text
    Journal Article
  7. 7

    In vitro testing of two formoterol dry powder inhalers at different flow rates by Weuthen, T, Roeder, S, Brand, P, Müllinger, B, Scheuch, G

    Published in Journal of aerosol medicine (01-09-2002)
    “…The efficiency of two different dry powder inhaler systems for the application of the beta2-sympathomimetic drug Formoterol in the lungs has been tested in…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10

    Inhalation of tobramycin in patients with cystic fibrosis: comparison of two methods by Dopfer, R, Brand, P, Müllinger, B, Hunger, T, Häussermann, S, Meyer, T, Scheuch, G, Siekmeier, R

    “…Inhalant tobramycin is established in the treatment of cystic fibrosis patients. Conventional nebulizers require a large amount of the expensive compound,…”
    Get full text
    Journal Article
  11. 11

    Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects by Scheuch, G, Brand, P, Meyer, T, Herpich, C, Müllinger, B, Brom, J, Weidinger, G, Kohlhäufl, M, Häussinger, K, Spannagl, M, Schramm, W, Siekmeier, R

    “…Inhalation of heparin results in local antiinflammatory and antifibrotic effects and an inhibition of blood coagulation. A number of experimental and clinical…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Comparison of unspecific bronchial provocation during controlled and spontaneous inhalation by Wenzel, C, Brand, P, Herpich, C, Häussermann, S, Meyer, T, Müllinger, B, Scheuch, G, Häussinger, K

    Published in Pneumologie (Stuttgart, Germany) (01-08-2006)
    “…Using controlled breathing patterns during inhalation of drugs is characterized by a high dose reproducibility which may be of advantage for bronchial…”
    Get more information
    Journal Article
  14. 14

    Peripheral deposition of α 1 ‐protease inhibitor using commercial inhalation devices by Brand, P., Beckmann, H., Maas Enriquez, M., Meyer, T., Müllinger, B., Sommerer, K., Weber, N., Weuthen, T., Scheuch, G.

    Published in The European respiratory journal (01-08-2003)
    “…Patients with hereditary α 1 ‐proteinase inhibitor (α 1 ‐PI) deficiency are at risk of developing lung emphysema. To prevent the development of this disease, α…”
    Get full text
    Journal Article
  15. 15

    Peripheral deposition of alpha1-protease inhibitor using commercial inhalation devices by Brand, P, Beckmann, H, Maas Enriquez, M, Meyer, T, Müllinger, B, Sommerer, K, Weber, N, Weuthen, T, Scheuch, G

    Published in The European respiratory journal (01-08-2003)
    “…Patients with hereditary alpha1-proteinase inhibitor (alpha1-PI) deficiency are at risk of developing lung emphysema. To prevent the development of this…”
    Get full text
    Journal Article
  16. 16
  17. 17

    A preliminary assessment of the impact of cranial osteopathy for the relief of infantile colic by Hayden, Clive, Mullinger, Brenda

    “…In this open, controlled, prospective study, 28 infants with colic were randomized to either cranial osteopathic manipulation or no treatment; all were seen…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Reprint of: A preliminary assessment of the impact of cranial osteopathy for the relief of infantile colic by Hayden, Clive, Mullinger, Brenda

    “…Abstract In this open, controlled, prospective study, 28 infants with colic were randomized to either cranial osteopathic manipulation or no treatment; all…”
    Get full text
    Journal Article
  20. 20

    Neonatal vaccination with 'universal strength' BCG vaccine by Heyworth, B, Mullinger, B M

    Published in Archives of disease in childhood (01-06-1977)
    “…'Universal strength' BCG vaccine was given to 219 neonates and 2 months later 159 infants were Mantoux-tested with 5 Tu PPD-S and their BCG scars measured. The…”
    Get full text
    Journal Article